GeneralConnection.com ➔ Dictionary
Dictionary Search

hemophilia a

Synonyms

Noun

1. hemophilia A

2. haemophilia A, classical hemophilia, classical haemophilia, hemophilia, haemophilia, bleeder's disease

Usage
Hemophilia Treatment Market Industry Report & Forecast 2035 - Business Research Insights
FDA expands Hympavzi approval to more hemophilia patients - Hemophilia News Today
FDA Expands Marstacimab Indication in Hemophilia A and B - Conexiant
Pfizer scores FDA pediatric expansion for hemophilia treatment Hympavzi - Fierce Pharma
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need - Yahoo Finance
Pfizer’s Hympavzi secures FDA expanded indications for haemophilia - Pharmaceutical Technology
Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors - NEJM
Health System News Helping Kids Thrive Through Hemophilia Program - oha.com
Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity - Nature
FDA Expands Pfizer’s Hympavzi Approval to Pediatric Hemophilia Patients and Those with Inhibitors - BioPharm International
Hemophilia A or B without inhibitors: marstacimab prophylaxis now an FDA-approved option from age 12 - Vera Health
Refractory Hemorrhage Following Total Knee Replacement Unmasking Acquired Hemophilia A - Cureus
US FDA Approves Pfizer’s Hympavzi for Children with Hemophilia - Новости GxP
Incyte inks $2B deal to add Star biz to late-phase constellation - Fierce Biotech
4 Things to Expect for the Future of Hemophilia Treatment - Docwire News
Pfizer’s Hympavzi Gets FDA Approval for Expanded Indication - Contract Pharma
PFE Gets FDA Nod for Expanded Use of Hemophilia Drug Hympavzi - Yahoo Finance
Prenatal cell and gene therapy for hemophilia A shows safety signs - Hemophilia News Today
US FDA approves Pfizer's bleeding disorder drug for children - Yahoo
Altuviiio safe, effective in patients with severe hemophilia A: Study - Hemophilia News Today
FDA grants fast track status to 1-time stem cell therapy for hemophilia A - Hemophilia News Today
Universal hope for hemophilia - The University of North Carolina at Chapel Hill
Overview of gene therapy for hemophilia: questions and answers to navigate the innovation - National Institutes of Health (.gov)
Activated factor VIII-mimetic prophylaxis associated with reduced bleeding in hemophilia A - 2 Minute Medicine
Real-world study backs safety of Hemlibra for acquired hemophilia A - Hemophilia News Today
Mim8 Prophylaxis Shows Durable Bleed Control at 52 Weeks in Hemophilia A - Docwire News
Lower-dose gene therapy effective in severe hemophilia A: Study - Hemophilia News Today
FDA approves new indication for Pfizer’s Hympavzi - The Pharma Letter
Global Hemophilia Survey Amplifies Patient and Caregiver Voices - Sanofi
Denecimig excels at reducing bleeds in hemophilia A patients: Study - Hemophilia News Today
Non-carrier mothers of hemophilia A patients with Inv22 inversions often have other rearrangements - National Institutes of Health (.gov)
3 years on Hemlibra keeps joints healthy in kids with hemophilia A - Hemophilia News Today
Denecimig (Mim8) significantly reduced annualized bleeding rate in people with hemophilia A, regardless of inhibitor status, in phase 3 data published in NEJM - PR Newswire
Improving Health-Related Quality of Life for Children With Hemophilia - Hematology Advisor
FDA Supports Advancement of GENV-HEM Gene Therapy for Hemophilia A - Docwire News
Longer Follow-Up Data Reinforce Concizumab’s Efficacy in Hemophilia A and B With Inhibitors - Docwire News
Geneventiv notes FDA ‘positive’ feedback on hemophilia A therapy - Hemophilia News Today
Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients - PR Newswire
Delayed diagnosis of hemophilia A presenting as chronic joint swelling: a case report - Frontiers
It’s Time to Look Beyond the Bleed - Sanofi
Hemlibra outperforms ITI in controlling bleeding in hemophilia A children - Hemophilia News Today
EnzySystem for hemophilia A could make home clotting tests easier - Hemophilia News Today
Hemophilia Studies Today: Points of Interest - Docwire News
An Initial Diagnosis of Acquired Hemophilia A in an Elderly Male With a Neck Hematoma - Cureus
BASIS Phase 3 Trial: Marstacimab Shows Itself a Versatile Hemophilia A, HB Prophylaxis - Docwire News
Marstacimab Superior to On-Demand Prophylaxis for Hemophilia A, B, With Inhibitors - Docwire News
New deal aims to bring BBM’s hemophilia A gene therapy to China - Hemophilia News Today
FDA approves expanded indication for Pfizer’s HYMPAVZI - grafa.com
New CAAR-T therapy may eliminate hemophilia A treatment blockers: Study - Hemophilia News Today
FDA may OK Hympavzi for children 6 and older with hemophilia A or B - Hemophilia News Today
A Multifactorial Case of Acquired Hemophilia A - Cureus
Phase 3 Analysis: Concizumab Noninferior to Prior Prophylaxis in Hemophilia A, B, Without Inhibitors - Docwire News
Abstract - 2026 - Haemophilia - Wiley Online Library
BASIS Phase 3 Trial: Marstacimab Shows Itself a Versatile Hemophilia A, HB Prophylaxis - Docwire News
Pfizer Reports Patient Death in Long-Term Trial of Hympavzi for Hemophilia A - BioSpace
Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A - MedPage Today
Michigan man gets new Roctavian gene therapy for hemophilia A - Detroit Free Press
Doctors warn eye bleeding can be first sign of hemophilia A - Hemophilia News Today
Efanesoctocog Alfa Improves Bleeding Regardless of Age in Hemophilia A, With Lynn Malec, MD, MSc - HCPLive
COVID-19-Associated Acquired Hemophilia A With an Exceptionally High Inhibitor Titer: A Case of Remission and Overwhelming Sepsis - Cureus
Efanesoctocog Alfa Improves Outcomes for Patients With Hemophilia A - Docwire News
Evolving treatment paradigms in hemophilia: A written recap - Managed Healthcare Executive
Hemlibra may help active men with hemophilia A stay in the game - Hemophilia News Today
Novo Nordisk Submits Denecimig (Mim8) BLA for Hemophilia A - HCPLive
FDA expands Hympavzi approval for hemophilia patients By Investing.com - Investing.com South Africa
Ongoing Trial Investigates Switching from Emicizumab to Fitusiran in Hemophilia A, With Guy Young, MD - HCPLive
Balancing the benefits and risks of rebalancing coagulation in haemophilia - The Lancet
FDA Approves Expanded Use of HYMPAVZI for Hemophilia Treatment in Adolescents - Intellectia AI
Exploring Eptacog Beta Dosing in Patients With Hemophilia A or B - Docwire News
Hand swelling is first sign of aquired hemophilia A for new mom: Report - Hemophilia News Today
Byron family shares son’s journey with Severe Hemophilia A - MyStateline
FRONTIER Trials Support BLA for Investigational Hemophilia A Drug - Docwire News
Novo Nordisk submits Biologics License Application (BLA) to FDA for Mim8; an investigational, prophylaxis treatment for people living with hemophilia A with or without inhibitors - PR Newswire
Phase 3 Study Evaluates Marstacimab for Hemophilia A, B, Without Inhibitors - Docwire News
Patients With Hemophilia Face Significant Burden Despite Treatment Type or Disease Severity - Docwire News
Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight - Yahoo Finance
Laboratory investigation and clinical management of acquired coagulation factor inhibitors: A joint British Society for Haematology and United Kingdom Haemophilia Centre Doctors' Organisation Guideline - Wiley Online Library
Marstacimab in the treatment of patients with hemophilia A and B - Via Medica Journals
BioMarin pulls hemophilia gene therapy Roctavian, taking $240M hit after divestiture efforts flounder - Fierce Pharma
Biomarin plans to sell rights to hemophilia A therapy Roctavian - Hemophilia News Today
Case Report: Coexisting cold agglutinin disease and acquired hemophilia A: a rituximab-responsive dual autoimmune disorder - Frontiers
Pfizer’s Hympavzi Indication Expanded in EU for Treatment of Hemophilia A or B With Inhibitors - Contract Pharma
Infection is top killer in acquired hemophilia A, study finds - Hemophilia News Today
Standard or low-dose rituximab effective for acquired hemophilia A - Hemophilia News Today
Safe Outpatient Dental Management of a Pediatric Patient With Mild Hemophilia A: A Case Report - Cureus
JW's Hemlibra effective in improving joint health, physical activity in hemophilia A patients - koreabiomed.com
Denecimig significantly reduced annualized bleeding rate in people with hemophilia A - The Pharma Letter
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors - Yahoo Finance
Acquired Hemophilia A With Post‐Phlebotomy Compartment Syndrome - Lam - 2025 - Clinical Case Reports - Wiley Online Library
Understanding Hemophilia A and B: Essential Insights for Pharmacists - Pharmacy Times
Newly ID’d F8 mutation could lead to better hemophilia A treatments - Hemophilia News Today
Diffuse alveolar hemorrhage in a child with mild hemophilia A who underwent bone marrow transplantation for thalassemia: a case report - Frontiers
BioMarin, following sluggish sales, to offload hemophilia gene therapy - BioPharma Dive
‘Dismissed’: A film that finally gives women with hemophilia a voice - Hemophilia News Today
Pfizer's HYMPAVZI Receives FDA Approval for Expanded Indications - Intellectia AI
Metagenomi Chops 25% of Workforce, CEO To Advance Hemophilia A Program - BioSpace
Hemophilia gene therapies are struggling on the market, even as innovation soars - Pharma Voice
'Gene therapy with 13-year durability pushes hemophilia closer to a functional cure' - koreabiomed.com
BioMarin resigned to ending journey with hemophilia A gene therapy Roctavian, seeks divestiture amid sales struggle - Fierce Pharma
FDA Approves Extended Indication for Concizumab-Mtci for Hemophilia A and B - Docwire News
Foreign Language Equivalents
Foreign Language Equivalents of 'hemophilia a'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
hemophilis a,   hemo[hilia a,   jemophilia a,   hemmophilia a,   hemophiliaa a,   hemophillia a,   hhemophilia a,   hemophi;ia a,   hmeophilia a,   hemopihlia a,   emophilia a,   hemophiliaa,   heomphilia a,   hemoophilia a,   hempphilia a,   hemphilia a,   hemophliia a,   hemophilia s,   hemophilai a,   gemophilia a,   hemophiloa a,   hwmophilia a,   hempohilia a,   hemophili a,   hemoohilia a,   hemophulia a,   heemophilia a,   heophilia a,   hemopjilia a,   hemophiliaa ,   hemophili aa,   hemophilia a,   hemohilia a,   hemophilia aa,   hemophiilia a,   he,ophilia a,   hemiphilia a,   henophilia a,   hemophikia a,   hemohpilia a,   hemophiila a,   hemopgilia a,   hemophilua a,   ehmophilia a,   hemopphilia a,   hrmophilia a,   hemophila a,   hmophilia a,   hemophilia ,   hemopilia a,   hemophlia a,   hemophiliia a,   hemophiia a,   hemopholia a,   hemophhilia a
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z